Everyday Prevention Evidence Editorial Team

By the Everyday Prevention Evidence Team When you see that a medicine is “in phase 3,” it means it is being studied in people before an FDA marketing decision—not that FDA approval has already …

Continue Reading about The 4 Phases of Clinical Trials: What FDA Review Means →

By the Everyday Prevention Evidence Team If you are asking for the top five study techniques, start with a routine, realistic scheduling, class notes, regular review, and practice questions. A simple …

Continue Reading about Top 5 Study Techniques: A Practical Guide →

By the Everyday Prevention Evidence Team If you are asking which clinical trials pay the most, look past a big dollar figure and ask what the study requires of you. Paid studies can cover time and …

Continue Reading about Which Clinical Trials Pay the Most? Pay, Risk and Time →

By the Everyday Prevention Evidence Team When a headline says a treatment "cut major health events by 30%," that number often isn't one event. It's a composite endpoint — several different events …

Continue Reading about Composite Endpoints: Which Events Actually Drove the Health Claim? →

By the Everyday Prevention Evidence Team A number without a timeline can mislead you Imagine a friend tells you a new medication has a "number needed to harm" (NNH) of 50 — meaning one extra person …

Continue Reading about Number Needed to Harm: Why the Time Period and Baseline Risk Matter →

By the Everyday Prevention Evidence Team You're looking at a "high certainty" label. What does that actually promise you? If you've ever read a research summary or a guideline table, you've probably …

Continue Reading about Why Evidence Gets Downgraded: Five GRADE Questions in Plain Language →